HIT000218960 promotes gastric cancer cell proliferation and migration through upregulation of HMGA2 expression

Sun,Leitao; Yu,Jieru; Wang,Peipei; Shen,Minhe; Ruan,Shanming

doi:10.3892/ol.2019.10176

HIT000218960 promotes gastric cancer cell proliferation and migration through upregulation of HMGA2 expression

Authors:
- Leitao Sun
- Jieru Yu
- Peipei Wang
- Minhe Shen
- Shanming Ruan
View Affiliations

Affiliations: First Clinical Medical College, Zhejiang Chinese Medicine University, Hangzhou, Zhejiang 310006, P.R. China, College of Basic Medical Science, Zhejiang Chinese Medicine University, Hangzhou, Zhejiang 310006, P.R. China, Department of Medical Oncology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310006, P.R. China
Published online on: March 21, 2019 https://doi.org/10.3892/ol.2019.10176
Pages: 4957-4963
Copyright: © Sun et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to elucidate whether the long non‑coding RNA (lncRNA) HIT000218960 could accelerate the proliferative and migratory ability of gastric cancer (GC) cells by regulating high‑mobility group AT‑hook 2 (HMGA2) gene. The reverse transcription‑quantitative polymerase chain reaction was used to determine HIT000218960 and HMGA2 expression levels in GC tissues and cells. The HMGA2 protein level was detected by western blotting. A χ2 test was used to determine the association between the HIT000218960 expression level and the clinical characteristics of patients with GC. GC cells were transfected with small interfering (si)‑negative control, si‑HIT000218960 and si‑HIT000218960+pcDNA‑HMGA2, prior to assessing the cell proliferative and migratory ability using the Cell Counting Kit‑8 and Transwell assays, respectively. HIT000218960 and HMGA2 were highly expressed in GC tissues compared with in healthy tissues. In addition, HIT000218960 and HMGA2 were positively correlated in GC tissues. The HIT000218960 expression level was associated with tumor size, Tumor‑Node‑Metastasis staging and lymph node metastasis in patients with GC. HIT000218960 silencing decreased the proliferative and migratory ability of HGC27 and NCI‑N87 cells; however, HMGA2 overexpression partly reversed this inhibitory effect. The results of the present study indicated that HIT000218960 could promote HGC27 and NCI‑N87 cell proliferation and migration, which may be mediated by HMGA2.

View Figures

View References

1	Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China, 2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
2	Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015. View Article : Google Scholar : PubMed/NCBI
3	Ilson DH: Adjuvant treatment for gastric cancer: Too much is not enough. Lancet Oncol. 15:788–789. 2014. View Article : Google Scholar : PubMed/NCBI
4	Bagcchi S: Radiotherapy for testicular cancer increases gastric cancer risk. Lancet Oncol. 15:e5932014. View Article : Google Scholar : PubMed/NCBI
5	Konishi H, Ichikawa D, Komatsu S, Shiozaki A, Tsujiura M, Takeshita H, Morimura R, Nagata H, Arita T, Kawaguchi T, et al: Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma. Br J Cancer. 106:740–747. 2012. View Article : Google Scholar : PubMed/NCBI
6	Zirtiloglu A, Cil I, Mehmet VF and Tural D: What are the optimal treatment modalities according to age group in gastric cancer patients? J Buon. 22:312–319. 2017.PubMed/NCBI
7	Spizzo R, Almeida MI, Colombatti A and Calin GA: Long non-coding RNAs and cancer: A new frontier of translational research? Oncogene. 31:4577–4587. 2012. View Article : Google Scholar : PubMed/NCBI
8	Batista PJ and Chang HY: Long noncoding RNAs: Cellular address codes in development and disease. Cell. 152:1298–1307. 2013. View Article : Google Scholar : PubMed/NCBI
9	Xia Y, Yan Z, Wan Y, Wei S, Bi Y, Zhao J, Liu J, Liao DJ and Huang H: Knockdown of long noncoding RNA GHET1 inhibits cellcycle progression and invasion of gastric cancer cells. Mol Med Rep. 18:3375–3381. 2018.PubMed/NCBI
10	Lv Z, Zhang Y, Yu X, Lin Y and Ge Y: The function of long non-coding RNA MT1JP in the development and progression of gastric cancer. Pathol Res Pract. 214:1218–1223. 2018. View Article : Google Scholar : PubMed/NCBI
11	Zhu C, Ma J, Li Y, Zhang Y and Da M: Low expression of long noncoding RNA MT1JP is associated with poor overall survival in gastric cancer patients: Protocol for meta-analysis. Medicine (Baltimore). 97:e103942018. View Article : Google Scholar : PubMed/NCBI
12	Shi X, Wang X and Hua Y: LncRNA GACAT1 promotes gastric cancer cell growth, invasion and migration by regulating miR-149-mediated of ZBTB2 and SP1. J Cancer. 9:3715–3722. 2018. View Article : Google Scholar : PubMed/NCBI
13	Yang F, Bi J, Xue X, Zheng L, Zhi K, Hua J and Fang G: Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells. Febs J. 279:3159–3165. 2012. View Article : Google Scholar : PubMed/NCBI
14	Liu G, Xiang T, Wu QF and Wang WX: Curcumin suppresses the proliferation of gastric cancer cells by downregulating H19. Oncol Lett. 12:5156–5162. 2016. View Article : Google Scholar : PubMed/NCBI
15	Yang F, Xue X, Bi J, Zheng L, Zhi K, Gu Y and Fang G: Long noncoding RNA CCAT1, which could be activated by c-Myc, promotes the progression of gastric carcinoma. J Cancer Res Clin Oncol. 139:437–445. 2013. View Article : Google Scholar : PubMed/NCBI
16	Henriksen J, Stabell M, Meza-Zepeda LA, Lauvrak SA, Kassem M and Myklebost O: Identification of target genes for wild type and truncated HMGA2 in mesenchymal stem-like cells. BMC Cancer. 10:3292010. View Article : Google Scholar : PubMed/NCBI
17	Sun T, Zhao N, Zhao XL, Gu Q, Zhang SW, Che N, Wang XH, Du J, Liu YX and Sun BC: Expression and functional significance of Twist1 in hepatocellular carcinoma: Its role in vasculogenic mimicry. Hepatology. 51:545–556. 2010. View Article : Google Scholar : PubMed/NCBI
18	Wagenblast E, Soto M, Gutierrez-Angel S, Hartl CA, Gable AL, Maceli AR, Erard N, Williams AM, Kim SY, Dickopf S, et al: A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasis. Nature. 520:358–362. 2015. View Article : Google Scholar : PubMed/NCBI
19	Williamson SC, Metcalf RL, Trapani F, Mohan S, Antonello J, Abbott B, Leong HS, Chester CP, Simms N, Polanski R, et al: Vasculogenic mimicry in small cell lung cancer. Nat Commun. 7:133222016. View Article : Google Scholar : PubMed/NCBI
20	Wang JY, Sun T, Zhao XL, Zhang SW, Zhang DF, Gu Q, Wang XH, Zhao N, Qie S and Sun BC: Functional significance of VEGF-a in human ovarian carcinoma: Role in vasculogenic mimicry. Cancer Biol Ther. 7:758–766. 2008. View Article : Google Scholar : PubMed/NCBI
21	Baeten CI, Hillen F, Pauwels P, de Bruine AP and Baeten CG: Prognostic role of vasculogenic mimicry in colorectal cancer. Dis Colon Rectum. 52:2028–2035. 2009. View Article : Google Scholar : PubMed/NCBI
22	Zhong X, Liu X, Li Y, Cheng M, Wang W, Tian K, Mu L, Zeng T, Liu Y, Jiang X, et al: HMGA2 sustains self-renewal and invasiveness of glioma-initiating cells. Oncotarget. 7:44365–44380. 2016. View Article : Google Scholar : PubMed/NCBI
23	Fujikane R, Komori K, Sekiguchi M and Hidaka M: Function of high-mobility group A proteins in the DNA damage signaling for the induction of apoptosis. Sci Rep. 6:317142016. View Article : Google Scholar : PubMed/NCBI
24	Yu H, Lim HH, Tjokro NO, Sathiyanathan P, Natarajan S, Chew TW, Klonisch T, Goodman SD, Surana U and Droge P: Chaperoning HMGA2 protein protects stalled replication forks in stem and cancer cells. Cell Rep. 6:684–697. 2014. View Article : Google Scholar : PubMed/NCBI
25	Tan EJ, Thuault S, Caja L, Carletti T, Heldin CH and Moustakas A: Regulation of transcription factor twist expression by the DNA architectural protein high mobility group A2 during epithelial-to-mesenchymal transition. J Biol Chem. 287:7134–7145. 2012. View Article : Google Scholar : PubMed/NCBI
26	Tan EJ, Kahata K, Idas O, Thuault S, Heldin CH and Moustakas A: The high mobility group A2 protein epigenetically silences the Cdh1 gene during epithelial-to-mesenchymal transition. Nucleic Acids Res. 43:162–178. 2015. View Article : Google Scholar : PubMed/NCBI
27	Li Y, Zhao Z, Xu C, Zhou Z, Zhu Z and You T: HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression. Cancer Lett. 355:130–140. 2014. View Article : Google Scholar : PubMed/NCBI
28	Singh I, Mehta A, Contreras A, Boettger T, Carraro G, Wheeler M, Cabrera-Fuentes HA, Bellusci S, Seeger W, Braun T and Barreto G: Hmga2 is required for canonical WNT signaling during lung development. BMC Biol. 12:212014. View Article : Google Scholar : PubMed/NCBI
29	Li T, Yang XD, Ye CX, Shen ZL, Yang Y, Wang B, Guo P, Gao ZD, Ye YJ, Jiang KW and Wang S: Long noncoding RNA HIT000218960 promotes papillary thyroid cancer oncogenesis and tumor progression by upregulating the expression of high mobility group AT-hook 2 (HMGA2) gene. Cell Cycle. 16:224–231. 2017. View Article : Google Scholar : PubMed/NCBI
30	Liu C, Ren L, Wang Y, Liu Y and Xiao J: The interaction between RACK1 and WEE1 regulates the growth of gastric cancer cell line HGC27. Oncol Lett. 14:4784–4792. 2017. View Article : Google Scholar : PubMed/NCBI
31	Kawai S, Kato S, Imai H, Okada Y and Ishioka C: Suppression of FUT1 attenuates cell proliferation in the HER2-overexpressing cancer cell line NCI-N87. Oncol Rep. 29:13–20. 2013. View Article : Google Scholar : PubMed/NCBI
32	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2^−ΔΔCt method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
33	Motoyama K, Inoue H, Nakamura Y, Uetake H, Sugihara K and Mori M: Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family. Clin Cancer Res. 14:2334–2340. 2008. View Article : Google Scholar : PubMed/NCBI
34	Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK, Lan F, Shi Y, Segal E and Chang HY: Long noncoding RNA as modular scaffold of histone modification complexes. Science. 329:689–693. 2010. View Article : Google Scholar : PubMed/NCBI
35	Xia YY, Yin L, Tian H, Guo WJ, Jiang N, Jiang XS, Wu J, Chen M, Wu JZ and He X: HMGA2 is associated with epithelial-mesenchymal transition and can predict poor prognosis in nasopharyngeal carcinoma. Onco Targets Ther. 8:169–176. 2015. View Article : Google Scholar : PubMed/NCBI
36	Xia YY, Yin L, Jiang N, Guo WJ, Tian H, Jiang XS, Wu J, Chen M, Wu JZ and He X: Downregulating HMGA2 attenuates epithelial-mesenchymal transition-induced invasion and migration in nasopharyngeal cancer cells. Biochem Biophys Res Commun. 463:357–363. 2015. View Article : Google Scholar : PubMed/NCBI